Summary
Provides national implementation guidance for health and care organizations adopting generative-AI ambient-scribing products. Version 2 aligns the guidance with the NHS Ambient Voice Technology Supplier Registry and addresses clinical-safety leadership, safety cases and hazard logs, data-protection impact assessments, medical-device status, procurement, system integration, piloting, human review, staff training, performance monitoring, bias, and supplier assurance.
Healthcare Implications
NHS organizations adopting AI scribes should establish clinical-safety and information-governance controls, require users to review and approve outputs, assess regulatory status, integrate products safely with patient records, independently monitor accuracy and incidents, evaluate performance across patient populations and speech characteristics, and ensure suppliers meet national and local assurance requirements.